Pancreatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Pages: 94 Published: June 30, 2022 Report Code: GDGMDHC22202IDB

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis – Drugs In Development, 2022, provides an overview of the Pancreatitis (Gastrointestinal) pipeline landscape.

Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pancreatitis – Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Pancreatitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pancreatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 8, 2, 16, 2 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Pancreatitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

* Global Markets Direct, is a research brand owned and operated by GlobalData.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatitis (Gastrointestinal).

– The pipeline guide reviews pipeline therapeutics for Pancreatitis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Pancreatitis (Gastrointestinal) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Pancreatitis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatitis (Gastrointestinal)

Reasons to Buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Pancreatitis (Gastrointestinal).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Pancreatitis (Gastrointestinal) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Players

AcelRx Pharmaceuticals Inc

Angion Biomedica Corp

Ariel Precision Medicine Inc

Beijing GeneCradle Technology Co Ltd

Bessor Pharma LLC

CalciMedica Inc

Centeer BioTherapeutics Ltd Co

Cypralis Ltd

D&D Pharmatech Co Ltd

Daewoong Pharmaceutical Co Ltd

DiaMedica Therapeutics Inc

Evive Biotech

GNT Pharma Co Ltd

GSK plc

Healx Ltd

HighTide Therapeutics Inc

JD Bioscience Inc

Johnson & Johnson

Kynos Therapeutics Ltd

Lamassu Pharma LLC

LipimetiX Development Inc

Mallinckrodt Plc

Panbela Therapeutics Inc

Path BioAnalytics Inc

PNB Vesper Life Science Pvt Ltd

Regeneron Pharmaceuticals Inc

Samsung Bioepis Co Ltd

SCM lifescience Co Ltd

Shionogi & Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Pancreatitis – Overview

Pancreatitis – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Pancreatitis – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Pancreatitis – Companies Involved in Therapeutics Development

Pancreatitis – Drug Profiles

Pancreatitis – Dormant Projects

Pancreatitis – Discontinued Products

Pancreatitis – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development for Pancreatitis, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Companies, 2022 (Contd..1)

Number of Products under Development by Universities/Institutes, 2022

Products under Development by Companies, 2022

Products under Development by Companies, 2022 (Contd..1)

Products under Development by Universities/Institutes, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Pancreatitis – Pipeline by AcelRx Pharmaceuticals Inc, 2022

Pancreatitis – Pipeline by Angion Biomedica Corp, 2022

Pancreatitis – Pipeline by Ariel Precision Medicine Inc, 2022

Pancreatitis – Pipeline by Beijing GeneCradle Technology Co Ltd, 2022

Pancreatitis – Pipeline by Bessor Pharma LLC, 2022

Pancreatitis – Pipeline by CalciMedica Inc, 2022

Pancreatitis – Pipeline by Centeer BioTherapeutics Ltd Co, 2022

Pancreatitis – Pipeline by Cypralis Ltd, 2022

Pancreatitis – Pipeline by D&D Pharmatech Co Ltd, 2022

Pancreatitis – Pipeline by Daewoong Pharmaceutical Co Ltd, 2022

Pancreatitis – Pipeline by DiaMedica Therapeutics Inc, 2022

Pancreatitis – Pipeline by Evive Biotech, 2022

Pancreatitis – Pipeline by GNT Pharma Co Ltd, 2022

Pancreatitis – Pipeline by GSK plc, 2022

Pancreatitis – Pipeline by Healx Ltd, 2022

Pancreatitis – Pipeline by HighTide Therapeutics Inc, 2022

Pancreatitis – Pipeline by JD Bioscience Inc, 2022

Pancreatitis – Pipeline by Johnson & Johnson, 2022

Pancreatitis – Pipeline by Kynos Therapeutics Ltd, 2022

Pancreatitis – Pipeline by Lamassu Pharma LLC, 2022

Pancreatitis – Pipeline by LipimetiX Development Inc, 2022

Pancreatitis – Pipeline by Mallinckrodt Plc, 2022

Pancreatitis – Pipeline by Panbela Therapeutics Inc, 2022

Pancreatitis – Pipeline by Path BioAnalytics Inc, 2022

Pancreatitis – Pipeline by PNB Vesper Life Science Pvt Ltd, 2022

Pancreatitis – Pipeline by Regeneron Pharmaceuticals Inc, 2022

Pancreatitis – Pipeline by Samsung Bioepis Co Ltd, 2022

Pancreatitis – Pipeline by SCM lifescience Co Ltd, 2022

Pancreatitis – Pipeline by Shionogi & Co Ltd, 2022

Pancreatitis – Dormant Projects, 2022

Pancreatitis – Dormant Projects, 2022 (Contd..1)

Pancreatitis – Discontinued Products, 2022

List of Figures

List of Figures

Number of Products under Development for Pancreatitis, 2022

Number of Products under Development by Companies, 2022

Number of Products by Top 10 Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Molecule Types, 2022

Frequently Asked Questions

Enquire Before Buying
$2000

Can be used by individual purchaser only

$6000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.